• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 26, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

New framework puts women’s heart disease prevention at puberty’s doorstep

by
October 26, 2026
in Health
Reading Time: 4 mins read
0
New framework puts women's heart disease prevention at puberty's doorstep

New framework puts women's heart disease prevention at puberty's doorstep

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Four of the most influential medical societies in the United States have jointly issued a coordinated framework that redefines where and when women’s cardiovascular care should begin: not at midlife, but around the time of a girl’s first menstrual period. The American Heart Association, the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine published three linked manuscripts in Circulation, the American Heart Association’s flagship journal, describing the first multi-society construct designed to prevent, detect and manage heart disease and stroke in girls and women across their entire lives.

The centerpiece of the joint guidance is a “Female Life Stage” framework that divides female cardiovascular health into four distinct stages, each anchored in a hormonal transition unique to female biology. Stage 1, perimenarche, covers the years around the first menstrual period, roughly ages 8 to 15, as hormone cycles mature. Stage 2, ovarian cycling, spans approximately ages 15 to 44, when regular ovulatory and hormone cycles are established and pregnancy may occur. Stage 3, perimenopause, describes the transition to variable cycle length, skipped cycles and shifting hormones, at approximately ages 45 to 51. Stage 4, postmenopause, begins after menopause or 12 months after the final menstrual period, at approximately age 51 and older. Pregnancy is treated separately as a “modifying life event” that can intersect with more than one stage.

The framework’s logic is that these hormonally defined windows offer concrete opportunities for earlier recognition of risk, earlier prevention and better continuity of care as patients move from pediatric to adult specialties. Amanda Marma Perak, MD, MSCI, a pediatric cardiologist at Ann & Robert H. Lurie Children’s Hospital of Chicago and Associate Professor of Pediatrics and Preventive Medicine at Northwestern University Feinberg School of Medicine, served as Vice-Chair of the collaborative volunteer writing group. “Heart health begins long before adulthood,” she said. “As pediatric clinicians, we have the opportunity to help every girl start strong and to ensure that what we learn about her health follows her as she grows.”

A central technical premise of the new guidance is that menstrual cycle patterns should be treated as a female-specific vital sign. “Periods can be a marker of heart health, and we now recognize menstrual cycle patterns as a female-specific vital sign,” said Dr. Marma Perak. Irregular cycles, the writing group notes, can signal conditions such as polyendocrine metabolic ovarian syndrome, formerly known as polycystic ovary syndrome or PCOS, that carry real cardiovascular risk. Heavy menstrual bleeding is identified as the most common cause of iron deficiency in young women, a condition that affects energy, activity and heart health. By embedding these observations into routine care from puberty onward, the framework allows female-specific prevention steps to start decades before traditional cardiovascular risk assessment typically begins.

Pregnancy receives particular emphasis as a biological “stress test” for the cardiovascular system. The guidance highlights the time before, during and after pregnancy, in any life stage, as a period that can unmask cardiovascular risks that may have gone previously unrecognized. This framing connects obstetric and maternal-fetal medicine directly to long-term cardiovascular prevention, since complications or risk signals detected around pregnancy can trigger follow-up that extends well beyond the postpartum period.

The joint publications consist of three coordinated documents. A Presidential Advisory, titled A Female-Specific Life Course Approach to the Prevention and Management of Cardiovascular Disease, establishes the female life stage construct and the life course framework. A Scientific Statement, Consensus Guidance for the Female-Specific Prevention and Management of Cardiovascular Disease, provides clinical guidance, including a multi-society guideline crosswalk designed to align recommendations across the participating specialties. A Science Advisory, Comprehensive Centers of Excellence for Women’s Cardiovascular Care, maps the current landscape of women’s cardiovascular centers and proposes a national infrastructure for coordinated care.

That proposed infrastructure is built on four pillars: interdisciplinary clinical care, professional education and training, research, and community engagement. The societies argue that existing tools and therapies already offer opportunities to improve cardiovascular health in girls and women now, while targeted research is needed to close evidence gaps specific to female biology. Their stated priorities include greater inclusion of girls and women in clinical research, expanded funding for women’s health, and translation of accumulated evidence into clinical action.

The papers were all prepared by the volunteer writing group on behalf of the four societies, and the framework’s practical promise, according to its authors, lies in connecting care across the clinical specialties that see women throughout their lives, from pediatrics to obstetrics and gynecology to adult cardiology. “The new female life stage framework allows us to start taking female-specific steps to prevent heart disease and stroke as early as puberty,” said Dr. Marma Perak. “This approach promises to be a significant advance for women’s health.”

Subject of Research: A multi-society framework for female-specific cardiovascular disease prevention across life stages

Article Title: Women’s heart health care starts at puberty: new shared framework from leading medical societies

Article References: Women’s heart health care starts at puberty: new shared framework from leading medical societies. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: cardiovascular disease, women's health, puberty, menstrual cycle, perimenopause, pregnancy, PCOS, prevention, pediatrics, American Heart Association, life course framework, Circulation

News Source: Frances Kline. (October 26, 2026). New framework puts women’s heart disease prevention at puberty’s doorstep. Scienmag.

Tags: American Heart AssociationCardiovascular diseaseCirculationlife course frameworkmenstrual cyclePCOSPediatricsperimenopausePregnancypreventionpubertywomen's health
Share12Tweet7Share2ShareShareShare1

Related Posts

First medulloblastoma case reported in O'Donnell–Luria–Rodan syndrome

First medulloblastoma case reported in O’Donnell–Luria–Rodan syndrome

October 26, 2026
Organoids and organ-on-a-chip models reshape radiation injury research

Organoids and organ-on-a-chip models reshape radiation injury research

October 26, 2026

Heart Scar Location and Size Track Distinct Left Atrial Faults in Dilated Cardiomyopathy

October 26, 2026

Fluoride confidence: why more facts alone fail to persuade hesitant caregivers

October 26, 2026

POPULAR NEWS

  • First medulloblastoma case reported in O'Donnell–Luria–Rodan syndrome

    First medulloblastoma case reported in O’Donnell–Luria–Rodan syndrome

    29 shares
    Share 12 Tweet 7
  • New framework puts women’s heart disease prevention at puberty’s doorstep

    29 shares
    Share 12 Tweet 7
  • Organoids and organ-on-a-chip models reshape radiation injury research

    29 shares
    Share 12 Tweet 7
  • Industrial microplastics blanket sediments of Swedish coastal archipelago

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

First medulloblastoma case reported in O’Donnell–Luria–Rodan syndrome

New framework puts women’s heart disease prevention at puberty’s doorstep

Organoids and organ-on-a-chip models reshape radiation injury research

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.